liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The (Ir)relevance of Group Size in Health Care Priority Setting: A Reply to Juth
Linköpings universitet, Institutionen för medicin och hälsa, Avdelningen för hälso- och sjukvårdsanalys. Linköpings universitet, Medicinska fakulteten. University of Borås, Sweden.ORCID-id: 0000-0003-0987-7653
Linköpings universitet, Institutionen för kultur och kommunikation, Avdelningen för kulturvetenskaper, KVA. Linköpings universitet, Filosofiska fakulteten.
2017 (engelsk)Inngår i: Health Care Analysis, ISSN 1065-3058, E-ISSN 1573-3394, Vol. 25, nr 1, s. 21-33Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

How to handle orphan drugs for rare diseases is a pressing problem in current health-care. Due to the group size of patients affecting the cost of treatment, they risk being disadvantaged in relation to existing cost-effectiveness thresholds. In an article by Niklas Juth it has been argued that it is irrelevant to take indirectly operative factors like group size into account since such a compensation would risk discounting the use of cost, a relevant factor, altogether. In this article we analyze Juths argument and observe that we already do compensate for indirectly operative factors, both outside and within cost-effectiveness evaluations, for formal equality reasons. Based on this we argue that we have reason to set cost-effectiveness thresholds to integrate equity concerns also including formal equality considerations. We find no reason not to compensate for group size to the extent we already compensate for other factors. Moreover, groups size implying a systematic disadvantage also on a global scale, i.e. taking different aspects of the health condition of patients suffering from rare diseases into account, will provide strong reason for why group size is indeed relevant to compensate for (if anything).

sted, utgiver, år, opplag, sider
SPRINGER , 2017. Vol. 25, nr 1, s. 21-33
Emneord [en]
Priority setting; Orphan drugs; Rare diseases; Equality; Formal equality; Justice; Cost-effectiveness
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-136654DOI: 10.1007/s10728-016-0333-3ISI: 000395099900002PubMedID: 27734213OAI: oai:DiVA.org:liu-136654DiVA, id: diva2:1089830
Tilgjengelig fra: 2017-04-21 Laget: 2017-04-21 Sist oppdatert: 2019-06-27

Open Access i DiVA

fulltext(404 kB)115 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 404 kBChecksum SHA-512
897896198c1912d6726a9f01de7dc9458a2069924fbb711bec013f54ba21b9b235d7e5a0213b91b37d5d6d589ea8b6daaeb6355740b290b5ccd5942daa330c93
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Søk i DiVA

Av forfatter/redaktør
Sandman, LarsGustavsson, Erik
Av organisasjonen
I samme tidsskrift
Health Care Analysis

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 115 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 171 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf